Targeting Cancer Represented In Iconic Race!
Targeting Cancer is delighted to announce the crew of Midnight Rambler will support the campaign and highlight the importance of radiation therapy as a cancer treatment in this year’s Sydney to Hobart yacht race.
The crew of the champion boat will promote Targeting Cancer during this year’s instalment of the iconic race, which gets underway on Boxing Day.
Midnight Rambler owner and skipper Ed Psaltis offered to support the campaign after discussions with David Sharp, one of the seven crew members joining Ed on the boat this year.
Midnight Rambler won the storm-ravaged 1998 edition of the race, while Psaltis has also won several other prestigious titles in his illustrious sailing career.
“We are absolutely delighted that the crew of Midnight Rambler have agreed to support us in this way,” Targeting Cancer Clinical Lead A/Prof Sandra Turner said. “It’s a fantastic gesture and a great way to promote the benefits of radiation therapy to the public.
“Many people don’t know that radiation therapy is a safe and highly effective treatment for cancer and cures many cancers. For instance, prostate cancer and head and neck cancers can often be cured with radiation therapy without the need for invasive surgery. When cancer is incurable, radiation therapy is very effective in relieving pain and improving quality of life.
“It’s so generous of Ed and the crew to show their support for the campaign in this way and we ask our supporters to cheer them on during this year’s race.”
Targeting Cancer is an initiative of The Royal Australian and New Zealand College of Radiologists’ Faculty of Radiation Oncology and aims to raise awareness of radiation therapy as a highly effective, sophisticated and cost-effective treatment for cancer among the public and health professionals.
“Targeting Cancer recently marked its fifth anniversary and during this time it’s made huge strides to promote the importance of radiation therapy, “A/Prof Turner said.
“Any health professionals who want to get involved should email email@example.com for more information. We welcome all support for the campaign, which aims to help patients make informed decisions about the right cancer treatment for them.”